{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T14:43:05Z","timestamp":1790174585484,"version":"4.1.0"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2014,10,20]],"date-time":"2014-10-20T00:00:00Z","timestamp":1413763200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2014,10,20]],"date-time":"2014-10-20T00:00:00Z","timestamp":1413763200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"DOI":"10.1038\/ncomms6268","type":"journal-article","created":{"date-parts":[[2014,10,20]],"date-time":"2014-10-20T12:28:14Z","timestamp":1413808094000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":46,"title":["Structure-guided discovery of potent and dual-acting human parainfluenza virus haemagglutinin\u2013neuraminidase inhibitors"],"prefix":"10.1038","volume":"5","author":[{"given":"Patrice","family":"Guillon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Larissa","family":"Dirr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ibrahim M.","family":"El-Deeb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moritz","family":"Winger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Bailly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Haselhorst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey C.","family":"Dyason","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"von Itzstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,10,20]]},"reference":[{"key":"BFncomms6268_CR1","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1128\/CMR.16.2.242-264.2003","volume":"16","author":"KJ Henrickson","year":"2003","unstructured":"Henrickson, K. J. Parainfluenza viruses. Clin. Microbiol. Rev. 16, 242\u2013264 (2003).","journal-title":"Clin. Microbiol. Rev."},{"key":"BFncomms6268_CR2","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1007\/978-1-4899-0036-4_19","volume":"Ch. 19","author":"WP Glezen","year":"1997","unstructured":"Glezen, W. P. & Denny, F. W. inViral Infection of Humans: Epidemiology and Control 4th edn Ch. 19, (eds Evans A. S., Kaslow R. A. 551\u2013568Plenum Press (1997).","journal-title":"Viral Infection of Humans: Epidemiology and Control"},{"key":"BFncomms6268_CR3","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1128\/CMR.00045-07","volume":"21","author":"WG Nichols","year":"2008","unstructured":"Nichols, W. G., Peck Campbell, A. J. & Boeckh, M. Respiratory viruses other than influenza virus: impact and therapeutic advances. Clin. Microbiol. Rev. 21, 274\u2013290 (2008).","journal-title":"Clin. Microbiol. Rev."},{"key":"BFncomms6268_CR4","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1086\/513975","volume":"175","author":"G Reed","year":"1997","unstructured":"Reed, G., Jewett, P. H., Thompson, J., Tollefson, S. & Wright, P. F. Epidemiology and clinical impact of parainfluenza virus infections in otherwise healthy infants and young children &lt;5 years old. J. Infect. Dis. 175, 807\u2013813 (1997).","journal-title":"J. Infect. Dis."},{"key":"BFncomms6268_CR5","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1093\/infdis\/161.3.402","volume":"161","author":"CA Heilman","year":"1990","unstructured":"Heilman, C. A. From the National Institute of Allergy and Infectious Diseases and the World Health Organization. Respiratory syncytial and parainfluenza viruses. J. Infect. Dis. 161, 402\u2013406 (1990).","journal-title":"J. Infect. Dis."},{"key":"BFncomms6268_CR6","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1093\/clinids\/18.5.770","volume":"18","author":"KJ Henrickson","year":"1994","unstructured":"Henrickson, K. J., Kuhn, S. M. & Savatski, L. L. Epidemiology and cost of infection with human parainfluenza virus types 1 and 2 in young children. Clin. Infect. Dis. 18, 770\u2013779 (1994).","journal-title":"Clin. Infect. Dis."},{"key":"BFncomms6268_CR7","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1016\/S0022-3476(86)81034-4","volume":"108","author":"FW Denny","year":"1986","unstructured":"Denny, F. W. & Clyde, W. A. J. Acute lower respiratory tract infections in non-hospitalized children. J. Pediatr. 108, 635\u2013646 (1986).","journal-title":"J. Pediatr."},{"key":"BFncomms6268_CR8","doi-asserted-by":"publisher","first-page":"S123","DOI":"10.1097\/INF.0b013e318168b76f","volume":"27","author":"M Sato","year":"2008","unstructured":"Sato, M. & Wright, P. F. Current status of vaccines for parainfluenza virus infections. Pediatr. Infect. Dis. J. 27, S123\u2013S125 (2008).","journal-title":"Pediatr. Infect. Dis. J."},{"key":"BFncomms6268_CR9","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1111\/j.1399-3046.2006.00654.x","volume":"11","author":"P De La Mora","year":"2007","unstructured":"De La Mora, P. & Moscona, A. A daring treatment and a successful outcome: the need for targeted therapies for pediatric respiratory viruses. Pediatr. Transplant. 11, 121\u2013123 (2007).","journal-title":"Pediatr. Transplant."},{"key":"BFncomms6268_CR10","doi-asserted-by":"publisher","first-page":"3975","DOI":"10.1016\/j.vaccine.2011.12.022","volume":"30","author":"RA Karron","year":"2012","unstructured":"Karron, R. A. et al. Evaluation of two chimeric bovine-human parainfluenza virus type 3 vaccines in infants and young children. Vaccine 30, 3975\u20133981 (2012).","journal-title":"Vaccine"},{"key":"BFncomms6268_CR11","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1086\/653621","volume":"202","author":"A Moscona","year":"2010","unstructured":"Moscona, A. et al. A recombinant sialidase fusion protein effectively inhibits human parainfluenza viral infection in vitro and in vivo. J. Infect. Dis. 202, 234\u2013241 (2010).","journal-title":"J. Infect. Dis."},{"key":"BFncomms6268_CR12","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1074\/jbc.M111.298059","volume":"287","author":"M Porotto","year":"2012","unstructured":"Porotto, M., Palmer, S. G., Palermo, L. M. & Moscona, A. Mechanism of fusion triggering by human parainfluenza virus type III: communication between viral glycoproteins during entry. J. Biol. Chem. 287, 778\u2013793 (2012).","journal-title":"J. Biol. Chem."},{"key":"BFncomms6268_CR13","doi-asserted-by":"publisher","first-page":"1688","DOI":"10.1172\/JCI25669","volume":"115","author":"A Moscona","year":"2005","unstructured":"Moscona, A. Entry of parainfluenza virus into cells as a target for interrupting childhood respiratory disease. J. Clin. Invest. 115, 1688\u20131698 (2005).","journal-title":"J. Clin. Invest."},{"key":"BFncomms6268_CR14","doi-asserted-by":"publisher","first-page":"8341","DOI":"10.1128\/JVI.00718-07","volume":"81","author":"M Amonsen","year":"2007","unstructured":"Amonsen, M., Smith, D. F., Cummings, R. D. & Air, G. M. Human parainfluenza viruses hPIV1 and hPIV3 bind oligosaccharides with alpha2-3-linked sialic acids that are distinct from those bound by H5 avian influenza virus hemagglutinin. J. Virol. 81, 8341\u20138345 (2007).","journal-title":"J. Virol."},{"key":"BFncomms6268_CR15","doi-asserted-by":"publisher","first-page":"31610","DOI":"10.1074\/jbc.M111.274217","volume":"286","author":"X Song","year":"2011","unstructured":"Song, X. et al. A sialylated glycan microarray reveals novel interactions of modified sialic acids with proteins and viruses. J. Biol. Chem. 286, 31610\u201331622 (2011).","journal-title":"J. Biol. Chem."},{"key":"BFncomms6268_CR16","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1093\/glycob\/cwr112","volume":"22","author":"IV Alymova","year":"2012","unstructured":"Alymova, I. V. et al. Receptor-binding specificity of the human parainfluenza virus type 1 hemagglutinin-neuraminidase glycoprotein. Glycobiology 22, 174\u2013180 (2012).","journal-title":"Glycobiology"},{"key":"BFncomms6268_CR17","doi-asserted-by":"publisher","first-page":"9152","DOI":"10.1128\/JVI.00888-07","volume":"81","author":"LM Palermo","year":"2007","unstructured":"Palermo, L. M., Porotto, M., Greengard, O. & Moscona, A. Fusion promotion by a paramyxovirus hemagglutinin-neuraminidase protein: pH modulation of receptor avidity of binding sites I and II. J. Virol. 81, 9152\u20139161 (2007).","journal-title":"J. Virol."},{"key":"BFncomms6268_CR18","doi-asserted-by":"publisher","first-page":"1495","DOI":"10.1128\/AAC.48.5.1495-1502.2004","volume":"48","author":"IV Alymova","year":"2004","unstructured":"Alymova, I. V. et al. Efficacy of novel hemagglutinin-neuraminidase inhibitors BCX 2798 and BCX 2855 against human parainfluenza viruses in vitro and in vivo. Antimicrob. Agents Chemother. 48, 1495\u20131502 (2004).","journal-title":"Antimicrob. Agents Chemother."},{"key":"BFncomms6268_CR19","doi-asserted-by":"publisher","first-page":"1655","DOI":"10.1016\/j.bmcl.2006.12.105","volume":"17","author":"DJ Tindal","year":"2007","unstructured":"Tindal, D. J. et al. Synthesis and evaluation of 4-O-alkylated 2-deoxy-2,3-didehydro-N-acetylneuraminic acid derivatives as inhibitors of human parainfluenza virus type-3 sialidase activity. Bioorg. Med. Chem. Lett. 17, 1655\u20131658 (2007).","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"BFncomms6268_CR20","doi-asserted-by":"publisher","first-page":"891","DOI":"10.3851\/IMP1420","volume":"14","author":"IV Alymova","year":"2009","unstructured":"Alymova, I. V. et al. Efficacy of the novel parainfluenza virus haemagglutinin-neuraminidase inhibitor BCX 2798 in mice\u2014further evaluation. Antivir. Ther. 14, 891\u2013898 (2009).","journal-title":"Antivir. Ther."},{"key":"BFncomms6268_CR21","doi-asserted-by":"publisher","first-page":"3942","DOI":"10.1128\/AAC.00220-09","volume":"53","author":"M Watanabe","year":"2009","unstructured":"Watanabe, M. et al. Effect of hemagglutinin-neuraminidase inhibitors BCX 2798 and BCX 2855 on growth and pathogenicity of Sendai\/human parainfluenza type 3 chimera virus in mice. Antimicrob. Agents Chemother. 53, 3942\u20133951 (2009).","journal-title":"Antimicrob. Agents Chemother."},{"key":"BFncomms6268_CR22","doi-asserted-by":"publisher","first-page":"2418","DOI":"10.1016\/j.bmc.2011.02.010","volume":"19","author":"R Nishino","year":"2011","unstructured":"Nishino, R. et al. Syntheses of 2-deoxy-2,3-didehydro-N-acetylneuraminic acid analogues modified by N-sulfonylamidino groups at the C-4 position and biological evaluation as inhibitors of human parainfluenza virus type 1. Bioorg. Med. Chem. 19, 2418\u20132427 (2011).","journal-title":"Bioorg. Med. Chem."},{"key":"BFncomms6268_CR23","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1248\/cpb.c12-00834","volume":"61","author":"R Nishino","year":"2013","unstructured":"Nishino, R. et al. Syntheses of 2-deoxy-2,3-didehydro-N-acetylneuraminic acid analogues modified by \u03b1-acylaminoamido groups at the C-4 position using isocyanide-based four-component coupling and biological evaluation as inhibitors of human parainfluenza virus type 1. Chem. Pharm. Bull. (Tokyo) 61, 69\u201374 (2013).","journal-title":"Chem. Pharm. Bull. (Tokyo)"},{"key":"BFncomms6268_CR24","doi-asserted-by":"publisher","first-page":"18447","DOI":"10.1021\/ja3084658","volume":"34","author":"M Winger","year":"2012","unstructured":"Winger, M. & von Itzstein, M. Exposing the flexibility of human parainfluenza virus hemagglutinin-neuraminidase. J. Am. Chem. Soc. 34, 18447\u201318452 (2012).","journal-title":"J. Am. Chem. Soc."},{"key":"BFncomms6268_CR25","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1016\/j.jmb.2003.11.032","volume":"335","author":"MC Lawrence","year":"2004","unstructured":"Lawrence, M. C. et al. Structure of the haemagglutinin-neuraminidase from human parainfluenza virus type III. J. Mol. Biol. 335, 1343\u20131357 (2004).","journal-title":"J. Mol. Biol."},{"key":"BFncomms6268_CR26","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/0008-6215(93)80014-6","volume":"244","author":"M von Itzstein","year":"1993","unstructured":"von Itzstein, M., Jin, B., Wu, W.-Y. & Chandler, M. A convenient method for the introduction of nitrogen and sulfur at C-4 on a sialic acid analogue. Carbohydr. Res. 244, 181\u2013185 (1993).","journal-title":"Carbohydr. Res."},{"key":"BFncomms6268_CR27","doi-asserted-by":"publisher","first-page":"1636","DOI":"10.1016\/j.carres.2007.06.002","volume":"342","author":"Y Lu","year":"2007","unstructured":"Lu, Y. & Gervay-Hague, J. Synthesis of C-4 and C-7 triazole analogs of zanamivir as multivalent sialic acid containing scaffolds. Carbohydr. Res. 342, 1636\u20131650 (2007).","journal-title":"Carbohydr. Res."},{"key":"BFncomms6268_CR28","doi-asserted-by":"publisher","first-page":"5009","DOI":"10.1016\/j.bmcl.2006.07.047","volume":"16","author":"J Li","year":"2006","unstructured":"Li, J. et al. Syntheses of triazole-modified zanamivir analogues via click chemistry and anti-AIV activities. Bioorg. Med. Chem. Lett. 16, 5009\u20135013 (2006).","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"BFncomms6268_CR29","unstructured":"Chand, P., Babu, Y. S., Rowland, S. R. & Lin, T.-H. Preparation of neuraminic acids and analogs useful for inhibiting paramyxovirus neuraminidase. PCT application WO2002076971 (2002)."},{"key":"BFncomms6268_CR30","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/0003-2697(79)90362-2","volume":"94","author":"M Potier","year":"1979","unstructured":"Potier, M., Mameli, L., B\u00e9lisle, M., Dallaire, L. & Melan\u00e7on, S. B. Fluorometric assay of neuraminidase with a sodium (4-methylumbelliferyl-alpha-D-N-acetylneuraminate) substrate. Anal. Biochem. 94, 287\u2013296 (1979).","journal-title":"Anal. Biochem."},{"key":"BFncomms6268_CR31","doi-asserted-by":"publisher","first-page":"11108","DOI":"10.1128\/JVI.74.23.11108-11114.2000","volume":"74","author":"O Greengard","year":"2000","unstructured":"Greengard, O., Poltoratskaia, N., Leikina, E., Zimmerberg, J. & Moscona, A. The anti-influenza virus agent 4-GU-DANA (zanamivir) inhibits cell fusion mediated by human parainfluenza virus and influenza virus HA. J. Virol. 74, 11108\u201311114 (2000).","journal-title":"J. Virol."},{"key":"BFncomms6268_CR32","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1023\/A:1013617232576","volume":"18","author":"T Suzuki","year":"2001","unstructured":"Suzuki, T. et al. Inhibition of human parainfluenza virus type 1 sialidase by analogs of 2-deoxy-2,3-didehydro-N-acetylneuraminic acid. Glycoconj. J. 18, 331\u2013337 (2001).","journal-title":"Glycoconj. J."},{"key":"BFncomms6268_CR33","doi-asserted-by":"publisher","first-page":"4604","DOI":"10.1128\/JVI.75.10.4604-4613.2001","volume":"75","author":"T Suzuki","year":"2001","unstructured":"Suzuki, T. et al. Receptor specificities of human respiroviruses. J. Virol. 75, 4604\u20134613 (2001).","journal-title":"J. Virol."},{"key":"BFncomms6268_CR34","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1002\/ajpa.10018","volume":"116","author":"A Varki","year":"2001","unstructured":"Varki, A. Loss of N-glycolylneuraminic acid in humans: mechanisms, consequences, and implications for hominid evolution. Am. J. Phys. Anthropol. 116, 54\u201369 (2001).","journal-title":"Am. J. Phys. Anthropol."},{"key":"BFncomms6268_CR35","doi-asserted-by":"publisher","first-page":"12387","DOI":"10.1128\/JVI.05570-11","volume":"85","author":"KC Bradley","year":"2011","unstructured":"Bradley, K. C. et al. Analysis of influenza virus hemagglutinin receptor binding mutants with limited receptor recognition properties and conditional replication characteristics. J. Virol. 85, 12387\u201312398 (2011).","journal-title":"J. Virol."},{"key":"BFncomms6268_CR36","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1006\/viro.1996.0321","volume":"220","author":"H Zhao","year":"1996","unstructured":"Zhao, H., De, B. P., Das, T. & Banerjee, A. K. Inhibition of human parainfluenza virus-3 replication by interferon and human MxA. Virology 220, 330\u2013338 (1996).","journal-title":"Virology"},{"key":"BFncomms6268_CR37","unstructured":"van Gunsteren, W. F. et al. Biomolecular Simulation: The GROMOS Manual and User Guide vdf Hochschulverlag, ETH Z\u00fcrich (1996)."},{"key":"BFncomms6268_CR38","doi-asserted-by":"publisher","first-page":"3596","DOI":"10.1021\/jp984217f","volume":"103","author":"WRP Scott","year":"1999","unstructured":"Scott, W. R. P. et al. The GROMOS biomolecular simulation program package. J. Phys. Chem. A 103, 3596\u20133607 (1999).","journal-title":"J. Phys. Chem. A"},{"key":"BFncomms6268_CR39","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1007\/s00249-011-0700-9","volume":"40","author":"N Schmid","year":"2011","unstructured":"Schmid, N. et al. Definition and testing of the GROMOS force-field versions: 54A7 and 54B7. Eur. Biophys. J. 40, 843\u2013856 (2011).","journal-title":"Eur. Biophys. J."},{"key":"BFncomms6268_CR40","doi-asserted-by":"publisher","first-page":"1656","DOI":"10.1002\/jcc.20090","volume":"25","author":"C Oostenbrink","year":"2004","unstructured":"Oostenbrink, C., Villa, A., Mark, A. E. & van Gunsteren, W. F. A biomolecular force field based on the free enthalpy of hydration and solvation: the GROMOS force-field parameter sets 53A5 and 53A6. J. Comput. Chem. 25, 1656\u20131676 (2004).","journal-title":"J. Comput. Chem."},{"key":"BFncomms6268_CR41","doi-asserted-by":"crossref","unstructured":"Berendsen H. J. C., Postma J. P. M., van Gunsteren W. F., Hermans J. inIntermolecular Forces (ed. Pullman B. 331\u2013342Reidel (1981).","DOI":"10.1007\/978-94-015-7658-1_21"},{"key":"BFncomms6268_CR42","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1016\/0021-9991(77)90098-5","volume":"23","author":"J-P Ryckaert","year":"1977","unstructured":"Ryckaert, J.-P., Ciccotti, G. & Berendsen, H. J. C. Numerical integration of cartesian equations of motion of a system with constraints\u2014molecular dynamics of n-alkanes. J. Comput. Phys. 23, 327\u2013341 (1977).","journal-title":"J. Comput. Phys."},{"key":"BFncomms6268_CR43","doi-asserted-by":"publisher","first-page":"5451","DOI":"10.1063\/1.469273","volume":"102","author":"IG Tironi","year":"1995","unstructured":"Tironi, I. G., Sperb, R., Smith, P. E. & van Gunsteren, W. F. A generalized reaction field method for molecular dynamics simulations. J. Chem. Phys. 102, 5451\u20135459 (1995).","journal-title":"J. Chem. Phys."},{"key":"BFncomms6268_CR44","doi-asserted-by":"publisher","first-page":"3684","DOI":"10.1063\/1.448118","volume":"81","author":"HJC Berendsen","year":"1984","unstructured":"Berendsen, H. J. C., Postma, J. P. M., van Gunsteren, W. F., Di Nola, A. & Haak, J. R. Molecular dynamics with coupling to an external bath. J. Chem. Phys. 81, 3684\u20133690 (1984).","journal-title":"J. Chem. Phys."},{"key":"BFncomms6268_CR45","doi-asserted-by":"publisher","first-page":"1719","DOI":"10.1002\/jcc.20303","volume":"26","author":"M Christen","year":"2005","unstructured":"Christen, M. et al. The GROMOS software for biomolecular simulation: GROMOS05. J. Comput. Chem. 26, 1719\u20131751 (2005).","journal-title":"J. Comput. Chem."},{"key":"BFncomms6268_CR46","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1006\/jmbi.1998.1885","volume":"280","author":"X Daura","year":"1998","unstructured":"Daura, X., Jaun, B., Seebach, D., van Gunsteren, W. F. & Mark, A. E. Reversible peptide folding in solution by molecular dynamics simulation. J. Mol. Biol. 280, 925\u2013932 (1998).","journal-title":"J. Mol. Biol."},{"key":"BFncomms6268_CR47","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1093\/protein\/8.2.127","volume":"8","author":"AC Wallace","year":"1996","unstructured":"Wallace, A. C., Laskowski, R. A. & Thornton, J. M. LIGPLOT: a program to generate schematic diagrams of protein-ligand interactions. Protein Eng. 8, 127\u2013134 (1996).","journal-title":"Protein Eng."},{"key":"BFncomms6268_CR48","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1016\/j.jmgm.2010.10.007","volume":"29","author":"JD Durrant","year":"2011","unstructured":"Durrant, J. D., de Oliveira, C. A. F. & McCammon, J. A. POVME: an algorithm for measuring binding-pocket volumes. J. Mol. Graphics Modell. 29, 773\u2013776 (2011).","journal-title":"J. Mol. Graphics Modell."},{"key":"BFncomms6268_CR49","doi-asserted-by":"publisher","first-page":"1872","DOI":"10.1248\/cpb.36.1872","volume":"36","author":"K Furuhata","year":"1988","unstructured":"Furuhata, K., Sato, S., Goto, M., Takayanagi, H. & Ogura, H. Studies on sialic acids. VII. The crystal and molecular structure of N-acetyl-2,3-dehydro-2-deoxyneuraminic acid. Chem. Pharm. Bull. 36, 1872\u20131876 (1988).","journal-title":"Chem. Pharm. Bull."},{"key":"BFncomms6268_CR50","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1007\/BF00731185","volume":"10","author":"CT Holzer","year":"1993","unstructured":"Holzer, C. T. et al. Inhibition of sialidases from viral, bacterial and mammalian sources by analogues of 2-deoxy-2,3-didehydro-N-acetylneuraminic acid modified at the C-4 position. Glycoconj. J. 10, 40\u201344 (1993).","journal-title":"Glycoconj. J."},{"key":"BFncomms6268_CR51","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1186\/1743-422X-3-63","volume":"3","author":"M Matrosovich","year":"2006","unstructured":"Matrosovich, M., Matrosovich, T., Garten, W. & Klenk, H.-D. New low-viscosity overlay medium for viral plaque assays. Virol. J. 3, 63 (2006).","journal-title":"Virol. J."},{"key":"BFncomms6268_CR52","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1128\/AAC.28.2.207","volume":"28","author":"FE Berkowitz","year":"1985","unstructured":"Berkowitz, F. E. & Levin, M. J. Use of an enzyme-linked immunosorbent assay performed directly on fixed infected cell monolayers for evaluating drugs against varicella-zoster virus. Antimicrob. Agents Chemother. 28, 207\u2013210 (1985).","journal-title":"Antimicrob. Agents Chemother."},{"key":"BFncomms6268_CR53","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/S0166-3542(98)00054-0","volume":"40","author":"EL St\u00e5hle","year":"1998","unstructured":"St\u00e5hle, E. L. et al. Solid phase ELISA for determination of the virus dose dependent sensitivity of human cytomegalovirus to antiviral drugs in vitro. Antiviral Res. 40, 105\u2013112 (1998).","journal-title":"Antiviral Res."},{"key":"BFncomms6268_CR54","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/S0166-0934(98)00150-5","volume":"77","author":"A Myc","year":"1999","unstructured":"Myc, A., Anderson, M. J. & Baker, J. R. Jr Optimization of in situ cellular ELISA performed on influenza A virus-infected monolayers for screening of antiviral agents. J. Virol. Methods 77, 165\u2013177 (1999).","journal-title":"J. Virol. Methods"},{"key":"BFncomms6268_CR55","doi-asserted-by":"publisher","first-page":"e51089","DOI":"10.1371\/journal.pone.0051089","volume":"7","author":"AC Koishi","year":"2012","unstructured":"Koishi, A. C., Zanello, P. R., Bianco, \u00c9. M., Bordignon, J. & Nunes Duarte dos Santos, C. Screening of dengue virus antiviral activity of marine seaweeds by an in situ enzyme-linked immunosorbent assay. PLoS ONE 7, e51089 (2012).","journal-title":"PLoS ONE"},{"key":"BFncomms6268_CR56","doi-asserted-by":"publisher","first-page":"1784","DOI":"10.1002\/(SICI)1521-3773(19990614)38:12<1784::AID-ANIE1784>3.0.CO;2-Q","volume":"38","author":"M Mayer","year":"1999","unstructured":"Mayer, M. & Meyer, B. Characterization of ligand binding by saturation transfer difference NMR spectroscopy. Angew. Chem. Int. Ed. 38, 1784\u20131788 (1999).","journal-title":"Angew. Chem. Int. Ed."},{"key":"BFncomms6268_CR57","doi-asserted-by":"publisher","first-page":"6108","DOI":"10.1021\/ja0100120","volume":"123","author":"M Mayer","year":"2001","unstructured":"Mayer, M. & Meyer, B. Group epitope mapping by saturation transfer difference NMR to identify segments of a ligand in direct contact with a protein receptor. J. Am. Chem. Soc. 123, 6108\u20136117 (2001).","journal-title":"J. Am. Chem. Soc."},{"key":"BFncomms6268_CR58","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1002\/anie.201004116","volume":"50","author":"T Haselhorst","year":"2011","unstructured":"Haselhorst, T. et al. Recognition of the GM3 ganglioside glycan by Rhesus rotavirus particles. Angew. Chem. Int. Ed. 50, 1055\u20131058 (2011).","journal-title":"Angew. Chem. Int. Ed."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/ncomms6268.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/ncomms6268","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/ncomms6268.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,6]],"date-time":"2023-01-06T02:49:27Z","timestamp":1672973367000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/ncomms6268"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,10,20]]},"references-count":58,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2014,12,23]]}},"alternative-id":["BFncomms6268"],"URL":"https:\/\/doi.org\/10.1038\/ncomms6268","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,10,20]]},"assertion":[{"value":"4 August 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 September 2014","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 October 2014","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing financial interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"5268"}}